New studies are revealing how medications that act on the glucagon-like peptide-1 (GLP-1) system influence brain networks tied to nausea, thirst, and reward-driven behaviors. GLP-1 drugs include commonly used treatments such as semaglutide (Ozempic, Wegovy), liraglutide (Victoza, Saxenda), and…
Category: 5. Health
-
Supercomputer creates the most realistic virtual brain ever
Using the strength of one of the fastest supercomputers on the planet, scientists have created one of the most comprehensive and biologically realistic animal brain simulations ever developed. This digital reconstruction of the entire mouse cortex gives researchers a new way to explore brain…
Continue Reading
-
In Mumbai, more than 80% of people who die due to extreme rainfall live in slums
MUMBAI, INDIA – SEPTEMBER 4: People walk through a flooded street following heavy monsoon rains at LBS road Kurla, on September 4, 2019 in Mumbai, India. Heavy rain pounded Mumbai on Wednesday, bringing the city to a halt. Train services were affected while streets were waterlogged, leading to…
Continue Reading
-
‘Vape! The Grease Parody’ Features The Humor And Harms Of E-Cigarettes
The off-Broadway musical discusses vaping in a satirical way but e-cigarettes can be harmful
Jeremy Daniel
When I first saw Grease on the big screen decades ago, little did I know that I would one day be watching an off-Broadway parody with vaping as the backdrop. Even less expected—that I would…
Continue Reading
-
See the alarming extent of NIH and NSF funding cuts in 2025
In 2025, more than 3,800 research grants from the National Institutes of Health and the National Science Foundation were terminated or frozen as part of the Trump administration’s effort to realign funding priorities.
Continue Reading
-
Scientists discover metformin may block key exercise benefits
A widely used medication for diabetes prevention may unexpectedly interfere with one of the most reliable ways to lower disease risk: regular physical activity.
A Rutgers-led team reported in The Journal of Clinical Endocrinology & Metabolism that metformin appeared to weaken several important…
Continue Reading
-
A silent kidney crisis is spreading faster than anyone expected
A growing number of people worldwide are now believed to have reduced kidney function, according to a new analysis. The number of affected individuals increased from 378 million in 1990 to 788 million in 2023. As populations have expanded and grown older, the condition has reached a point where…
Continue Reading
-
UnitedHealth Group Taps Former FDA Chief And Medicare Advisor To Board
UnitedHealth Group Tuesday named former U.S. Food and Drug Administration commissioner Dr. Scott Gottlieb, to its board of directors, the company announced Nov. 18, 2025. In this photo, Dr. Gottlieb, testifies during a House Energy and Commerce Committee hearing concerning federal efforts to…
Continue Reading
-
Funding chaos may unravel decades of biomedical research
Megan Murray has been in limbo. The Harvard University epidemiologist and infectious diseases doctor has grants from the U.S. National Institutes of Health to fund ongoing research on tuberculosis. Over decades, her work has produced insights on how TB spreads, how genetic and
Continue Reading
-
I treat menopause and its symptoms, and hormone replacement therapy can help – here’s the science behind the FDA’s decision to remove warnings
For more than 20 years, hormone therapy for menopause has carried a warning label from the Food and Drug Administration describing the medication’s risk of serious harms – namely, cancer, cardiovascular disease and possibly dementia.
On Nov. 10, 2025, the FDA announced that drugmakers…
Continue Reading